Baltimore Washington Financial Advisors, Inc. Haemonetics Corp Transaction History

Baltimore Washington Financial Advisors, Inc.

$1.8 Billion
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 14, 2022	BUY	$49.55 - $74.59 $12.4 Million - $18.7 Million	250,517 New	250,517 $9,000

Others Institutions Holding HAE

# of Institutions

333

Shares Held

54M

Call Options Held

689K

Put Options Held

345K

Black Rock Inc. New York, NY

5.96M
Shares

$489 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$424 Million
0.01% of portfolio
Capital Research Global Investors Los Angeles, CA

4.44M
Shares

$365 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

4.2M
Shares

$345 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

4.03M
Shares

$331 Million
0.26% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.21B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Baltimore Washington Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baltimore Washington Financial Advisors, Inc. with notifications on news.

Account